Gordon Carl Linsider trades
In SEC Form 4 filings, Gordon Carl L is listed as Director, 10% owner of ADARx Pharmaceuticals, Inc. (ADRX) and Director, 10% owner of Electra Therapeutics, Inc. (ETRA). In the last 90 days, Gordon Carl L bought $36.15M across 2 companies on the open market and sold none. The largest purchase was $15.00M of Electra Therapeutics, Inc. (ETRA) on Sep 21. Took part in 2 cluster buys; the latest at ADARx Pharmaceuticals, Inc. (ADRX), where 5 insiders bought within 1 day, ending Sep 28.
Companies and roles
Cluster buys
Form 4 historysince 2026-09-23
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C | 10,690,530 | not reported | not reported | 10,690,530 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C | 2,000,962 | not reported | not reported | 12,691,492 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C | 769,601 | not reported | not reported | 13,461,093 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C | 564,187 | not reported | not reported | 14,025,280 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | P | 300,249 | $17.00 | Purchase +$5,104,233 | 14,325,529 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C | 7,127,019 | not reported | not reported | 7,127,019 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C | 1,333,975 | not reported | not reported | 8,460,994 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C | 513,067 | not reported | not reported | 8,974,061 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C | 256,448 | not reported | not reported | 9,230,509 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | P | 61,516 | $17.00 | Purchase +$1,045,772 | 9,292,025 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | P | 588,235 | $17.00 | Purchase +$9,999,995 | 588,235 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C · derivative | 10,690,530 | $0.00 | $0 | not reported | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C · derivative | 2,000,962 | $0.00 | $0 | not reported | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C · derivative | 769,601 | $0.00 | $0 | not reported | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C · derivative | 564,187 | $0.00 | $0 | not reported | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C · derivative | 7,127,019 | $0.00 | $0 | not reported | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C · derivative | 1,333,975 | $0.00 | $0 | not reported | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C · derivative | 513,067 | $0.00 | $0 | not reported | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C · derivative | 256,448 | $0.00 | $0 | not reported | No | Form 4 |
| ETRAElectra Therapeutics, Inc. | Sep 21 | Sep 23 | C | 2,002,310 | not reported | not reported | 2,002,310 | No | Form 4 |
| ETRAElectra Therapeutics, Inc. | Sep 21 | Sep 23 | C | 1,087,934 | not reported | not reported | 3,090,244 | No | Form 4 |
| ETRAElectra Therapeutics, Inc. | Sep 21 | Sep 23 | C | 1,703,314 | not reported | not reported | 4,793,558 | No | Form 4 |
| ETRAElectra Therapeutics, Inc. | Sep 21 | Sep 23 | P | 333,333 | $15.00 | Purchase +$4,999,995 | 5,126,891 | No | Form 4 |
| ETRAElectra Therapeutics, Inc. | Sep 21 | Sep 23 | C | 758,279 | not reported | not reported | 758,279 | No | Form 4 |
| ETRAElectra Therapeutics, Inc. | Sep 21 | Sep 23 | P | 1,000,000 | $15.00 | Purchase +$15,000,000 | 1,758,279 | No | Form 4 |
| ETRAElectra Therapeutics, Inc. | Sep 21 | Sep 23 | C · derivative | 2,002,310 | $0.00 | $0 | not reported | No | Form 4 |
| ETRAElectra Therapeutics, Inc. | Sep 21 | Sep 23 | C · derivative | 1,087,934 | $0.00 | $0 | not reported | No | Form 4 |
| ETRAElectra Therapeutics, Inc. | Sep 21 | Sep 23 | C · derivative | 1,703,314 | $0.00 | $0 | not reported | No | Form 4 |
| ETRAElectra Therapeutics, Inc. | Sep 21 | Sep 23 | C · derivative | 758,279 | $0.00 | $0 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.